Global Obesity Treating Neuromodulation System Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 97

Report ID: 6527

Neuromodulation has shown some benefit in treatment of obesity and it is less invasive than the gastric banding and gastric bypass, which are surgical treatment option for obesity. Obesity treating neuromodulation system works by manipulation the appetite signal between gut and the brain.
North America region dominates the global obesity treating neuromodulation system market and is expected to continue to dominate the market over the forecast period. High adoption of neuromodulation system and increased regulatory approval of these devices in the region is expected to be factor for the growth of obesity treating neuromodulation system market. Europe is the second biggest market for the obesity treating neuromodulation system. Increasing prevalence of obesity and presence of market players is also driving the market of obesity treating neuromodulation system market in North America and Europe.

The global Obesity Treating Neuromodulation System market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Obesity Treating Neuromodulation System volume and value at global level, regional level and company level. From a global perspective, this report represents overall Obesity Treating Neuromodulation System market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Medtronic
Cyberonics
St. Jude Medical
BioControl Medical
Leptos Medical
EnteroMedics
Nevro
Nuvectra

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Vagus Nerve Stimulator
Splanchnic Nerve Stimulator
Deep Brain Stimulator
Spinal Cord Stimulator
Autonomous Nerve Stimulator
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers

Table of Contents

Executive Summary
1 Obesity Treating Neuromodulation System Market Overview
1.1 Product Overview and Scope of Obesity Treating Neuromodulation System
1.2 Obesity Treating Neuromodulation System Segment by Type
1.2.1 Global Obesity Treating Neuromodulation System Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Vagus Nerve Stimulator
1.2.3 Splanchnic Nerve Stimulator
1.2.4 Deep Brain Stimulator
1.2.5 Spinal Cord Stimulator
1.2.6 Autonomous Nerve Stimulator
1.2.7 Others
1.3 Obesity Treating Neuromodulation System Segment by Application
1.3.1 Obesity Treating Neuromodulation System Consumption Comparison by Application (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Obesity Treating Neuromodulation System Market by Region
1.4.1 Global Obesity Treating Neuromodulation System Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Obesity Treating Neuromodulation System Market Size
1.5.1 Global Obesity Treating Neuromodulation System Revenue (2014-2025)
1.5.2 Global Obesity Treating Neuromodulation System Production (2014-2025)

2 Global Obesity Treating Neuromodulation System Market Competition by Manufacturers
2.1 Global Obesity Treating Neuromodulation System Production Market Share by Manufacturers (2014-2019)
2.2 Global Obesity Treating Neuromodulation System Revenue Share by Manufacturers (2014-2019)
2.3 Global Obesity Treating Neuromodulation System Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Obesity Treating Neuromodulation System Production Sites, Area Served, Product Types
2.5 Obesity Treating Neuromodulation System Market Competitive Situation and Trends
2.5.1 Obesity Treating Neuromodulation System Market Concentration Rate
2.5.2 Obesity Treating Neuromodulation System Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Obesity Treating Neuromodulation System Production Market Share by Regions
3.1 Global Obesity Treating Neuromodulation System Production Market Share by Regions
3.2 Global Obesity Treating Neuromodulation System Revenue Market Share by Regions (2014-2019)
3.3 Global Obesity Treating Neuromodulation System Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Obesity Treating Neuromodulation System Production
3.4.1 North America Obesity Treating Neuromodulation System Production Growth Rate (2014-2019)
3.4.2 North America Obesity Treating Neuromodulation System Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Obesity Treating Neuromodulation System Production
3.5.1 Europe Obesity Treating Neuromodulation System Production Growth Rate (2014-2019)
3.5.2 Europe Obesity Treating Neuromodulation System Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Obesity Treating Neuromodulation System Production (2014-2019)
3.6.1 China Obesity Treating Neuromodulation System Production Growth Rate (2014-2019)
3.6.2 China Obesity Treating Neuromodulation System Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Obesity Treating Neuromodulation System Production (2014-2019)
3.7.1 Japan Obesity Treating Neuromodulation System Production Growth Rate (2014-2019)
3.7.2 Japan Obesity Treating Neuromodulation System Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Obesity Treating Neuromodulation System Consumption by Regions
4.1 Global Obesity Treating Neuromodulation System Consumption by Regions
4.2 North America Obesity Treating Neuromodulation System Consumption (2014-2019)
4.3 Europe Obesity Treating Neuromodulation System Consumption (2014-2019)
4.4 China Obesity Treating Neuromodulation System Consumption (2014-2019)
4.5 Japan Obesity Treating Neuromodulation System Consumption (2014-2019)

5 Global Obesity Treating Neuromodulation System Production, Revenue, Price Trend by Type
5.1 Global Obesity Treating Neuromodulation System Production Market Share by Type (2014-2019)
5.2 Global Obesity Treating Neuromodulation System Revenue Market Share by Type (2014-2019)
5.3 Global Obesity Treating Neuromodulation System Price by Type (2014-2019)
5.4 Global Obesity Treating Neuromodulation System Production Growth by Type (2014-2019)

6 Global Obesity Treating Neuromodulation System Market Analysis by Applications
6.1 Global Obesity Treating Neuromodulation System Consumption Market Share by Application (2014-2019)
6.2 Global Obesity Treating Neuromodulation System Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Obesity Treating Neuromodulation System Business
7.1 Medtronic
7.1.1 Medtronic Obesity Treating Neuromodulation System Production Sites and Area Served
7.1.2 Obesity Treating Neuromodulation System Product Introduction, Application and Specification
7.1.3 Medtronic Obesity Treating Neuromodulation System Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Cyberonics
7.2.1 Cyberonics Obesity Treating Neuromodulation System Production Sites and Area Served
7.2.2 Obesity Treating Neuromodulation System Product Introduction, Application and Specification
7.2.3 Cyberonics Obesity Treating Neuromodulation System Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 St. Jude Medical
7.3.1 St. Jude Medical Obesity Treating Neuromodulation System Production Sites and Area Served
7.3.2 Obesity Treating Neuromodulation System Product Introduction, Application and Specification
7.3.3 St. Jude Medical Obesity Treating Neuromodulation System Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 BioControl Medical
7.4.1 BioControl Medical Obesity Treating Neuromodulation System Production Sites and Area Served
7.4.2 Obesity Treating Neuromodulation System Product Introduction, Application and Specification
7.4.3 BioControl Medical Obesity Treating Neuromodulation System Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Leptos Medical
7.5.1 Leptos Medical Obesity Treating Neuromodulation System Production Sites and Area Served
7.5.2 Obesity Treating Neuromodulation System Product Introduction, Application and Specification
7.5.3 Leptos Medical Obesity Treating Neuromodulation System Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 EnteroMedics
7.6.1 EnteroMedics Obesity Treating Neuromodulation System Production Sites and Area Served
7.6.2 Obesity Treating Neuromodulation System Product Introduction, Application and Specification
7.6.3 EnteroMedics Obesity Treating Neuromodulation System Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Nevro
7.7.1 Nevro Obesity Treating Neuromodulation System Production Sites and Area Served
7.7.2 Obesity Treating Neuromodulation System Product Introduction, Application and Specification
7.7.3 Nevro Obesity Treating Neuromodulation System Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Nuvectra
7.8.1 Nuvectra Obesity Treating Neuromodulation System Production Sites and Area Served
7.8.2 Obesity Treating Neuromodulation System Product Introduction, Application and Specification
7.8.3 Nuvectra Obesity Treating Neuromodulation System Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served

8 Obesity Treating Neuromodulation System Manufacturing Cost Analysis
8.1 Obesity Treating Neuromodulation System Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Obesity Treating Neuromodulation System
8.4 Obesity Treating Neuromodulation System Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Obesity Treating Neuromodulation System Distributors List
9.3 Obesity Treating Neuromodulation System Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Obesity Treating Neuromodulation System Market Forecast
11.1 Global Obesity Treating Neuromodulation System Production, Revenue Forecast
11.1.1 Global Obesity Treating Neuromodulation System Production Growth Rate Forecast (2019-2025)
11.1.2 Global Obesity Treating Neuromodulation System Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Obesity Treating Neuromodulation System Price and Trend Forecast (2019-2025)
11.2 Global Obesity Treating Neuromodulation System Production Forecast by Regions (2019-2025)
11.2.1 North America Obesity Treating Neuromodulation System Production, Revenue Forecast (2019-2025)
11.2.2 Europe Obesity Treating Neuromodulation System Production, Revenue Forecast (2019-2025)
11.2.3 China Obesity Treating Neuromodulation System Production, Revenue Forecast (2019-2025)
11.2.4 Japan Obesity Treating Neuromodulation System Production, Revenue Forecast (2019-2025)
11.3 Global Obesity Treating Neuromodulation System Consumption Forecast by Regions (2019-2025)
11.3.1 North America Obesity Treating Neuromodulation System Consumption Forecast (2019-2025)
11.3.2 Europe Obesity Treating Neuromodulation System Consumption Forecast (2019-2025)
11.3.3 China Obesity Treating Neuromodulation System Consumption Forecast (2019-2025)
11.3.4 Japan Obesity Treating Neuromodulation System Consumption Forecast (2019-2025)
11.4 Global Obesity Treating Neuromodulation System Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Obesity Treating Neuromodulation System Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer